NetraMark Holdings's book value per share for the quarter that ended in Mar. 2024 was C$0.00.
During the past 12 months, NetraMark Holdings's average Book Value Per Share Growth Rate was -98.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -32.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of NetraMark Holdings was -32.40% per year. The lowest was -32.40% per year. And the median was -32.40% per year.
NetraMark Holdings's current price is C$0.27. Its book value per share for the quarter that ended in Mar. 2024 was C$0.00. Hence, today's PB Ratio of NetraMark Holdings is 90.00.
During the past 4 years, the highest P/B Ratio of NetraMark Holdings was 113.33. The lowest was 0.64. And the median was 1.88.
NetraMark Holdings Book Value per Share Historical Data
The historical data trend for NetraMark Holdings's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of NetraMark Holdings's Book Value per Share
For the Health Information Services subindustry, NetraMark Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings's PB Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's PB Ratio falls into.
NetraMark Holdings Book Value per Share Calculation
NetraMark Holdings's Book Value Per Share for the fiscal year that ended in Sep. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
NetraMark Holdings (XCNQ:AIAI) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
NetraMark Holdings Book Value per Share Related Terms
Thank you for viewing the detailed overview of NetraMark Holdings's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
NetraMark Holdings (XCNQ:AIAI) Business Description
NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XCNQ:AIAI has been successfully added to your 